APA

Cooles F. A. H., Anderson A. E., Drayton T., Harry R. A., Diboll J., Munro L., Thalayasingham N., Östör A. J. K. & Isaacs J. D. (20171108). Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapies. : Arthritis research & therapy.

Chicago

Cooles Faye A H, Anderson Amy E, Drayton Tracey, Harry Rachel A, Diboll Julie, Munro Lee, Thalayasingham Nishanthi, Östör Andrew J K and Isaacs John D. 20171108. Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapies. : Arthritis research & therapy.

Harvard

Cooles F. A. H., Anderson A. E., Drayton T., Harry R. A., Diboll J., Munro L., Thalayasingham N., Östör A. J. K. and Isaacs J. D. (20171108). Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapies. : Arthritis research & therapy.

MLA

Cooles Faye A H, Anderson Amy E, Drayton Tracey, Harry Rachel A, Diboll Julie, Munro Lee, Thalayasingham Nishanthi, Östör Andrew J K and Isaacs John D. Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapies. : Arthritis research & therapy. 20171108.